Stocksigma LogoStocksigma Logo

US FDA Issues Warning Letter for Alkem Laboratories Amaliya Facility

Alkem Laboratories received a Warning Letter dated 18th Nov'26 from the US FDA for its manufacturing facility located at Amaliya, Daman

US FDA Issues Warning Letter for Alkem Laboratories Amaliya Facility

Alkem Laboratories Ltd 路 Others (Uncategorized) 路 19 Nov 2026, 7:01 pm

US FDA Issues Warning Letter for Alkem Laboratories Amaliya Facility Alkem Laboratories received a Warning Letter dated 18th Nov'26 from the US FDA for its manufacturing facility located at Amaliya, Daman. This follows an inspection conducted between 20th Apr'26 and 1st May'26, which was previously classified as Official Action Indicated (OAI). The company stated it will respond within the stipulated timeline and continues to manufacture and supply approved products to the U.S. market. The warning letter currently presents no material impact on operations or financials.

Original exchange filing (PDF)

More announcements from Alkem Laboratories Ltd

All Alkem Laboratories Ltd announcements